Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine · Shinde A, Mohan A, Bulusu VM et al.

Factors contributing to AMR in India

Global estimates indicate that only 50% of the global antibiotic consumption is appropriately justified (Iskandar et al., 2020). Dispensing antimicrobial drugs without prescription by pharmacies in the private sector in India within an urban setting was unacceptably high (around 67%) (Shet et al., 2015). Reports indicate that 44% of outpatient antibiotic prescriptions are intended to inappropriately treat acute respiratory conditions (e.g., viral upper respiratory tract infections, bronchitis, asthma, allergies, and influenza) (Laxminarayan and Chaudhury, 2016). In India nearly 60% mortality of children aged 5 to 14 years is due to infectious diseases such as diarrhea, pneumonia, measles, etc (Morris et al., 2011). The rate of infectious disease is also linked with increased sale and consumption of antibiotic in India. The lack of diagnostic facilities, irrational prescription, lack of knowledge, experience about antibiotic use and pharma companies’ incentives are the factors which cause misuse of antibiotics.

Unregulated OTC dispensing of antibiotics

A 2018 study found that more than 60% of fixed drug combinations (FDCs) had no regulatory approval (McGettigan et al., 2019). They found many formulations were pharmacologically incompatible, reinforcing the need for better regulation and oversight of the pharmaceutical industry. Schedule H1, an amendment to the Drugs and Cosmetics Rules Act of 1945 that imposed restrictions on OTC dispensing of certain antibiotics (mostly third and fourth-generation cephalosporins, carbapenems, and newer fluoroquinolones) was perceived as a vital policy with ineffective implementation and adherence (Nair et al., 2023). Universal coverage of vaccines is expected to prevent 11.4 million days of antibiotic use per year in children less than 5 years of age. Consequently shows an estimated 47% reduction in antibiotics used to treat these pneumococcal infections (Wu et al., 2021).

Economic and healthcare access barriers contributing to AMR

Due to healthcare costs, patients avoid diagnostic and purchase antibiotics without a prescription and self-medicate with older prescriptions to have a rapid recovery. These collectively promote the misuse of antibiotics and increase AMR (Jani et al., 2021). In rural areas, many healthcare providers are often inefficient and employ unqualified staff. Thereby, urging the patients to choose private healthcare, which leads to high costs, particularly for the middle-class and low-income earners. To cut this expense, patients turn to self-medication, which results in high consumption of antibiotics. The observation validates the finding of Wu et al (Wu et al., 2021), which highlighted a rise in parents self-medicating their children (below 5 yrs), posing a serious threat to child health. This behavior causes AMR to first-generation and broad-spectrum antibiotics (Gandra et al., 2017).

Environmental contribution to AMR

Antibiotics are extensively used to compensate for poor sanitation, prevent diseases in herds/flocks, treat bacterial infections, and to promote animal growth in the distinct agricultural sectors (Page and Gautier, 2012). The magnitude and contribution of cross-reservoir resistance transmission from animals to humans is difficult to quantify and track mainly because of globalized food trade (Mather et al., 2013). Wastewater is flagged as a significant environmental reservoir of drug-resistant bacteria; horizontal gene transfer of antimicrobial resistance genes (ARGs) results in the dissemination of AMR in microbial communities. India has become the center for MDR and XDR Mycobacterium tuberculosis, which complicates the control of tuberculosis. In addition, the genomic flexibility of many resistant organisms allows them to acquire resistance to reserved antibiotics like carbapenem and colistin (Jani et al., 2021).